GPRO - PRISM Mid-Day Movers: Vascular Graft Sale to U.S Military Boosts MedDevices Index
2025-07-23 13:01:29 ET
Humacyte Rises 19% on First Military Sale of Bioengineered Vascular Device
Humacyte, Inc. ( HUMA ) climbed 19.17% to lead the PRISM Emerging MedDevices Index after announcing its first sale of the FDA-approved Symvess(TM) bioengineered vascular graft to a U.S. Military Treatment Facility . The sale follows the company's recent listing on the Department of Defense's ECAT purchasing system, enabling distribution to over 190 VA and military hospitals. Symvess, cleared for extremity vascular trauma repair, is positioned as a critical innovation for trauma surgery, particularly in combat and emergency settings.
Other PRISM Mid-Day Movers:
- GoPro, Inc. ( GPRO ) up 48.27%
- Palisade Bio, Inc. ( PALI ) up 29.65%
- INmune Bio, Inc. ( INMB ) up 17.13%
- Intuitive Machines, Inc. ( LUNR ) up 14.54%
The post PRISM Mid-Day Movers: Vascular Graft Sale to U.S Military Boosts MedDevices Index appeared first on PRISM MarketView .
COMTEX_467508110/2927/2025-07-23T12:01:29